Unlike single-pathway peptides, retatrutide aims to control multiple metabolic triggers at once, creating more sustainable shifts in hunger, cravings, nutrient use, and basal metabolic rate
Efficacy and safety of switching to once-weekly semaglutide from dulaglutide or exenatide once weekly in patients with type 2 diabetes (SUSTAIN 7): a multicentre, open-label, randomised, phase 3b trial
Wegovy is to be used in addition to a reduced calorie diet and increased physical activity.
Semaglutide has been shown to promote long-term weight loss when combined with lifestyle changes
2017;12:e0180989
Two brain regions that have GLP-1 receptors present are the ventral tegmental area and nucleus accumbens, which happen to be critical in the development of substance use disorders, where addictive substances hijack natural reward pathways, leading to compulsive behaviors